Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
MBI Quote, Financials, Valuation and Earnings
Last price:
$4.76
Seasonality move
:
7.2%
Day range:
$4.54 - $4.79
52-week range:
$3.22 - $7.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.29x
P/B ratio:
--
Volume:
213.6K
Avg. volume:
187.7K
1-year change:
-6.3%
Market cap:
$239.8M
Revenue:
$42M
EPS (TTM):
-$8.86
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $282M | $159M | $154M | $7M | $42M | |
| Revenue Growth (YoY) | 0.36% | -43.62% | -3.15% | -95.46% | 500% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $92M | $127M | $76M | $98M | $86M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $228M | $181M | $180M | $211M | $209M | |
| EBT. Incl. Unusual Items | -$578M | -$445M | -$148M | -$484M | -$441M | |
| Earnings of Discontinued Ops. | -- | -- | -$54M | -$3M | -$3M | |
| Income Tax Expense | -- | -- | $1M | -- | -- | |
| Net Income to Company | -$578M | -$445M | -$149M | -$484M | -$441M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$578M | -$445M | -$203M | -$487M | -$444M | |
| Basic EPS (Cont. Ops) | -$9.78 | -$8.99 | -$3.92 | -$10.18 | -$9.43 | |
| Diluted EPS (Cont. Ops) | -$9.78 | -$8.99 | -$3.92 | -$10.18 | -$9.43 | |
| Weighted Average Basic Share | $59.1M | $49.5M | $49.8M | $48.2M | $47.4M | |
| Weighted Average Diluted Share | $59.1M | $49.5M | $49.8M | $48.2M | $47.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$350M | -$264M | $32M | -$273M | -$232M | |
| Revenue (Reported) | $282M | $159M | $154M | $7M | $42M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$350M | -$264M | $32M | -$273M | -$232M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $72M | $40M | $2M | $13M | $14M | |
| Revenue Growth (YoY) | -- | -44.44% | -95% | 550% | 7.69% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $28M | $21M | $26M | $29M | $17M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $50M | $41M | $51M | $52M | $50M | |
| EBT. Incl. Unusual Items | -$106M | -$73M | -$83M | -$87M | -$62M | |
| Earnings of Discontinued Ops. | -- | -- | -$3M | $1M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$106M | -$73M | -$83M | -$87M | -$62M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$106M | -$73M | -$86M | -$86M | -$62M | |
| Basic EPS (Cont. Ops) | -$2.16 | -$1.48 | -$1.86 | -$1.84 | -$1.28 | |
| Diluted EPS (Cont. Ops) | -$2.16 | -$1.48 | -$1.86 | -$1.84 | -$1.28 | |
| Weighted Average Basic Share | $49.3M | $49.6M | $49.9M | $46.8M | $48.4M | |
| Weighted Average Diluted Share | $49.3M | $49.6M | $49.9M | $46.8M | $48.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$56M | -$32M | -$32M | -$35M | -$12M | |
| Revenue (Reported) | $72M | $40M | $2M | $13M | $14M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$56M | -$32M | -$32M | -$35M | -$12M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $360M | $127M | $116M | $18M | $43M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $100M | $120M | $85M | $101M | $75M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $216M | $172M | $190M | $212M | $206M | |
| EBT. Incl. Unusual Items | -$351M | -$412M | -$158M | -$488M | -$416M | |
| Earnings of Discontinued Ops. | -- | -- | -$57M | $2M | -$4M | |
| Income Tax Expense | -- | -- | $1M | -- | -- | |
| Net Income to Company | -$351M | -$412M | -$159M | -$488M | -$416M | |
| Minority Interest in Earnings | -- | -- | -- | $1M | -$4M | |
| Net Income to Common Excl Extra Items | -$351M | -$412M | -$216M | -$480M | -$421M | |
| Basic EPS (Cont. Ops) | -$6.60 | -$8.32 | -$4.30 | -$10.17 | -$8.86 | |
| Diluted EPS (Cont. Ops) | -$6.60 | -$8.32 | -$4.45 | -$10.17 | -$8.86 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$135M | -$240M | $32M | -$276M | -$210M | |
| Revenue (Reported) | $360M | $127M | $116M | $18M | $43M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$135M | -$240M | $32M | -$276M | -$210M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $72M | $40M | $2M | $13M | $14M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $28M | $21M | $26M | $29M | $17M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $50M | $41M | $51M | $52M | $50M | |
| EBT. Incl. Unusual Items | -$106M | -$73M | -$83M | -$87M | -$62M | |
| Earnings of Discontinued Ops. | -- | -- | -$3M | $1M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$106M | -$73M | -$83M | -$87M | -$62M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$106M | -$73M | -$86M | -$86M | -$62M | |
| Basic EPS (Cont. Ops) | -$2.16 | -$1.48 | -$1.86 | -$1.84 | -$1.28 | |
| Diluted EPS (Cont. Ops) | -$2.16 | -$1.48 | -$1.86 | -$1.84 | -$1.28 | |
| Weighted Average Basic Share | $49.3M | $49.6M | $49.9M | $46.8M | $48.4M | |
| Weighted Average Diluted Share | $49.3M | $49.6M | $49.9M | $46.8M | $48.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$56M | -$32M | -$32M | -$35M | -$12M | |
| Revenue (Reported) | $72M | $40M | $2M | $13M | $14M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$56M | -$32M | -$32M | -$35M | -$12M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $167M | $160M | $66M | $107M | $87M | |
| Short Term Investments | $2.5B | $2.5B | $2.2B | $1.6B | $1.4B | |
| Accounts Receivable, Net | $1.9B | $1.5B | $297M | $329M | $318M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.6B | $4.2B | $2.5B | $2B | $1.8B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $2.8B | $2.8B | $2.7B | $2B | $1.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.8B | $4.7B | $3.4B | $2.6B | $2.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $3.6B | $3.2B | $3.1B | $3.2B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.6B | $5B | $4.3B | $4.3B | $4.2B | |
| Common Stock | $283M | $283M | $283M | $283M | $283M | |
| Other Common Equity Adj | $115M | $100M | -$283M | -$139M | -$128M | |
| Common Equity | $136M | -$313M | -$882M | -$1.7B | -$2.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $13M | $13M | $6M | $10M | $13M | |
| Total Equity | $149M | -$300M | -$876M | -$1.6B | -$2.1B | |
| Total Liabilities and Equity | $5.8B | $4.7B | $3.4B | $2.6B | $2.2B | |
| Cash and Short Terms | $2.7B | $2.7B | $2.2B | $1.7B | $1.5B | |
| Total Debt | $3.6B | $3.2B | $3.1B | $3.2B | $3.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $121M | $151M | $83M | $137M | $63M | |
| Short Term Investments | $2.8B | $3.1B | $2.3B | $1.5B | $1.4B | |
| Accounts Receivable, Net | $1.8B | $543M | $255M | $324M | $324M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.8B | $3.8B | $2.7B | $1.9B | $1.8B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $3.1B | $3.5B | $2.3B | $1.8B | $1.6B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.4B | $4.4B | $3.3B | $2.5B | $2.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $3.4B | $3.2B | $3.1B | $3.1B | $3.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.4B | $5B | $4.2B | $4.2B | $4.2B | |
| Common Stock | $283M | $283M | $283M | $283M | $283M | |
| Other Common Equity Adj | $39M | -$82M | -$221M | -$131M | -$99M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $13M | $13M | $13M | $10M | $13M | |
| Total Equity | -$28M | -$552M | -$899M | -$1.7B | -$2.1B | |
| Total Liabilities and Equity | $5.4B | $4.4B | $3.3B | $2.5B | $2.1B | |
| Cash and Short Terms | $3B | $3.3B | $2.4B | $1.6B | $1.5B | |
| Total Debt | $3.4B | $3.2B | $3.1B | $3.1B | $3.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$578M | -$445M | -$149M | -$484M | -$441M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $45M | $412M | $152M | -$32M | $11M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$390M | $511M | -$418M | -$195M | -$176M | |
| Capital Expenditures | -- | $1M | -- | -- | -- | |
| Cash Acquisitions | -- | -- | $2M | -$2M | -- | |
| Cash From Investing | $1.7B | -$61M | $623M | $767M | $287M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$409M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $2M | $62M | $8M | |
| Long-Term Debt Repaid | -$1B | -$456M | -$238M | -$157M | -$122M | |
| Repurchase of Common Stock | -$200M | -$1M | -$3M | -$38M | -$4M | |
| Other Financing Activities | -$36M | -- | -$46M | -$5M | -$5M | |
| Cash From Financing | -$1.3B | -$457M | -$285M | -$542M | -$132M | |
| Beginning Cash (CF) | $83M | $167M | $160M | $78M | $108M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $83M | -$7M | -$80M | $30M | -$21M | |
| Ending Cash (CF) | $167M | $160M | $78M | $108M | $87M | |
| Levered Free Cash Flow | -$390M | $510M | -$418M | -$195M | -$176M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$61M | -$36M | -$78M | -$253M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $70M | -$90M | -$6M | $37M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $16M | -$41M | -$42M | -$10M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $308M | $242M | $243M | $120M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$96M | -$143M | -$48M | -$48M | -- | |
| Repurchase of Common Stock | -- | -- | -$24M | -$2M | -- | |
| Other Financing Activities | -$2M | -- | $2M | -- | -- | |
| Cash From Financing | -$98M | -$143M | -$68M | -$50M | -- | |
| Beginning Cash (CF) | $121M | $151M | $93M | $138M | -- | |
| Foreign Exchange Rate Adjustment | -- | -$2M | -- | -- | -- | |
| Additions / Reductions | $226M | $58M | $133M | $60M | -- | |
| Ending Cash (CF) | $347M | $207M | $226M | $198M | -- | |
| Levered Free Cash Flow | $16M | -$41M | -$42M | -$10M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$351M | -$412M | -$159M | -$488M | -$416M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $14M | $749M | -$198M | -$70M | $1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $221M | $255M | -$727M | -$189M | -$189M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | $2M | -$2M | -- | |
| Cash From Investing | $710M | $103M | $948M | $829M | $186M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $64M | $6M | |
| Long-Term Debt Repaid | -$862M | -$328M | -$231M | -$208M | -$56M | |
| Repurchase of Common Stock | -$139M | -$2M | -$5M | -$36M | -$9M | |
| Other Financing Activities | -- | $1M | -$46M | -$7M | -- | |
| Cash From Financing | -$1B | -$329M | -$276M | -$595M | -$72M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$97M | $29M | -$55M | $45M | -$75M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $221M | $255M | -$727M | -$189M | -$189M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$167M | -$109M | -$161M | -$340M | -$62M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $125M | $302M | $36M | $41M | -$6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $545M | $232M | -$78M | -$40M | -$43M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$110M | -$12M | $314M | $253M | $32M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $2M | -- | |
| Long-Term Debt Repaid | -$252M | -$171M | -$69M | -$120M | -$6M | |
| Repurchase of Common Stock | -$1M | -$2M | -$28M | -$4M | -$7M | |
| Other Financing Activities | -$2M | $1M | $3M | -$1M | -- | |
| Cash From Financing | -$255M | -$172M | -$88M | -$123M | -$13M | |
| Beginning Cash (CF) | $288M | $311M | $171M | $246M | $87M | |
| Foreign Exchange Rate Adjustment | -- | -$1M | -- | -- | -- | |
| Additions / Reductions | $180M | $48M | $148M | $90M | -$24M | |
| Ending Cash (CF) | $468M | $358M | $319M | $336M | $63M | |
| Levered Free Cash Flow | $545M | $232M | -$78M | -$40M | -$43M | |
Get MBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MBI
Sector
P/E ratio
--
12.21x
PEG ratio
-0.02x
0.40x
P/B ratio
--
1.11x
Price / LTM sales
5.29x
2.66x
Growth Metrics
MBI
Sector
Revenue growth
7.69%
5.12%
Earnings growth
--
2.63%
Revenue (5-year growth)
-31.62%
5.17%
Earnings forecast
-$0.08
$0.61
Profitability
MBI
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
-34.81%
5.21%
Return on assets
-18.59%
0.97%
Return on equity
--
9.24%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
7
Balance Sheet
MBI
Sector
Total cash
$1.5B
$451.2M
Short term investments
$1.4B
$220.9M
Total assets
$2.2B
$3.8B
Long term debt
$3.3B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
